Rheumatology Advance Access originally published online on March 18, 2009
Rheumatology 2009 48(5):464-465; doi:10.1093/rheumatology/kep048
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
EDITORIALS |
Small effects of treatments for non-specific low back pain: how can we improve patients outcomes?
1Arthritis Research Campaign National Primary Centre, Keele University, Keele, UK and 2VU University Medical Centre, Amsterdam, The Netherlands
Correspondence to: Daniëlle van der Windt, Arthritis Research Campaign, National Primary Care Centre, Primary Care Sciences, Keele University, Keele, Staffordshire, ST5 5BG. E-mail: d.van.der.windt@cphc.keele.ac.uk
| The first 10% of the full text of this article appears below. |
Machado et al. [1] in a recent systematic meta-analysis conclude that the analgesic effects of many treatments for non-specific low back pain (NSLBP) are small. An increasingly large effort is being expended in the research on treatments for NSLBP, represented by the long trail of more than 1000 publications on randomized trials in the past 25 years, and numerous systematic reviews summarizing the evidence for potentially beneficial interventions. For a very common health problem, with major impact on everyday activities and large socioeconomic consequences, this is a desirable situation. However, it is paralleled by an equally growing realization among the back pain research community that more and more trials and reviews are failing to show clear superiority or benefit of any particular treatment, with